Aspirin use improves colon cancer survival for those who have a specific mutation called PIK3CA

Madely Health Headlines Commentary for October 25, 2012

Source:

Aspirin has selective benefit in colorectal cancer

Reference:

X. Liao et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. New England Journal of Medicine, Volume 367, Oct. 25, 2012, p. 1596. doi: 1056/NEJMoa1207756

Bitnami